Francis A. Farraye MD
Adjunct Professor, Gastroenterology
85 E. Concord St | (617) 638-8339
Center for Regenerative Medicine
Evans Center for Interdisciplinary Biomedical Research
Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he co-directs the Inflammatory Bowel Disease Center. Prior to relocating in 2019, he was Clinical Director in the Section of Gastroenterology and the Inflammatory Bowel Disease Center at Boston Medical Center. At Chobanian and Avedisian School of Medicine, he was Professor of Medicine. Dr. Farraye earned his medical doctorate from the Albert Einstein College of Medicine in New York and his master's degree in Epidemiology from the Harvard School of Public Health.
Dr. Farraye's clinical interests are in the care of patients with inflammatory bowel disease. He is currently investigating C. difficile infection in IBD patients, the management and diagnosis of dysplasia and cancer in patients with IBD; social media use and health literacy in IBD patients; hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD.
A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis, Questions and Answers about Crohn's Disease and Ulcerative Colitis for Dummies.
Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn's and Colitis Foundation Membership Committee and a member of the Chapter Medical Advisory Committee for the New England Crohn's and Colitis Foundation and a past chairman. The New England Crohn's and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. Dr. Farraye has been recognized as "Top Doctor" in Gastroenterology by Boston Magazine and U.S. News and World Report since 2010.
MD, Albert Einstein College of Medicine, 1982
Epidemiology, MSc, Harvard School of Public Health, 2001
BS, Stony Brook University, 1978
Caldera F, Spaulding AC, Hayney MS, Farraye FA. Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors' reply. Aliment Pharmacol Ther. 2023 Jun; 57(11):1345-1346. PMID: 37161632.Published on 5/17/2023
Loeb L, Nasir A, Picco MF, Hashash JG, Kinnucan JA, Farraye FA. Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 May 17. PMID: 37196096.Published on 5/13/2023
Karime C, Hashash JG, Farraye FA. Measuring of Post-vaccination Hepatitis-B Titers in Patients with Inflammatory Bowel Disease: Thoughts for Further Investigation. Clin Gastroenterol Hepatol. 2023 May 13. PMID: 37187325.Published on 5/11/2023
Itzkowitz S, Farraye FA, Limburg P, Gagrat Z, Olson MC, Zella J, Kisiel J. Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study. J Crohns Colitis. 2023 May 11. PMID: 37166153.Published on 5/2/2023
El Hage Chehade N, Ghoneim S, Shah S, Chahine A, Mourad FH, Francis FF, Binion DG, Farraye FA, Hashash JG. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Inflamm Bowel Dis. 2023 May 02; 29(5):808-817. PMID: 35766805.Published on 4/26/2023
Kuriakose Kuzhiyanjal AJ, Nigam GB, Antoniou GA, Farraye FA, Cross RK, Limdi JK. Management of Inflammatory Bowel Disease Using E-Health Technologies: A Systematic Review and Meta-Analysis. J Crohns Colitis. 2023 Apr 26. PMID: 37099723.Published on 4/24/2023
Bali AS, Hashash JG, Picco MF, Kinnucan JA, Farraye FA. Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training. Am J Gastroenterol. 2023 Apr 24. PMID: 36940436.Published on 4/18/2023
Schell TL, Ramirez O, Almasry M, Farraye FA, Hayney MS, Caldera F. Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Apr 18. PMID: 37071782.Published on 4/12/2023
Singer D, Thompson-Leduc P, Gupta D, Cheng WY, Poston S, Ma S, Pawlowski JE, Duh MS, Morris ED, Devine F, Farraye FA. Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA. Gastroenterol Rep (Oxf). 2023; 11:goad016. PMID: 37064550.Published on 4/7/2023
Nelson AD, Fluxá D, Caldera F, Farraye FA, Hashash JG, Kröner PT. Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2023 Jun; 68(6):2597-2603. PMID: 37027107.
Published on 4/1/2019
11 GI Leaders To Know In MarchView full list of 1 media mentions.